Distribution of extended-spectrum beta-lactamase genes using a commercial DNA micro-array system

Journal of Hospital Infection

Volumn 79, Issue 4, 2011, Pages 349-353

  Nijhuis, R H T ^a   van Zwet, A A ^a   Savelkoul, P H M ^b   Roovers, E A ^c   Bosboom, R W ^d   Postma, B ^e   van Griethuysen, A J ^a  

^a Rijnstate Velp ^*  (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c Clinical Research Department   (Netherlands)

^d SLINGELAND HOSPITAL   (Netherlands)

^e GELDERSE VALLEI HOSPITAL   (Netherlands)

Author keywords

CTX M; Epidemiology; Extended spectrum beta lactamases; Micro array

Indexed keywords

EXTENDED SPECTRUM BETA LACTAMASE;

ARTICLE; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CONTROLLED STUDY; DNA MICROARRAY; ENTEROBACTER CLOACAE; ESCHERICHIA COLI; GENE IDENTIFICATION; GENETIC ASSOCIATION; HOSPITAL PATIENT; HUMAN; HUMAN TISSUE; INTENSIVE CARE UNIT; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; NONHUMAN;

BACTERIOLOGICAL TECHNIQUES; BETA-LACTAMASES; GENES, BACTERIAL; GRAM-NEGATIVE BACTERIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; NETHERLANDS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PREVALENCE;

EID: 81055156082     PISSN: 01956701     EISSN: 15322939     Source Type: Journal    
DOI: 10.1016/j.jhin.2011.08.005     Document Type: Article

References (24)

1. Endimiani A., Hujer A.M., Hujer K.M., et al. Evaluation of a commercial microarray system for detection of SHV-, TEM-, CTX-M-, and KPC-type beta-lactamase genes in Gram-negative isolates. J Clin Microbiol 2010, 48:2618-2622.
2. Nijssen S., Florijn A., Bonten M.J.M., Schmitz F.J., Verhoef J., Fluit A.C. Beta-lactam susceptibilities and prevalence of ESBL-producing isolates among more than 5000 European Enterobacteriaceae isolates. Int J Antimicrob Agents 2004, 24:585-591.
3. Valverde A., Coque T.M., Sánchez-Moreno M.P., Rollán A., Baquero F., Cantón R. Dramatic increase in prevalence of fecal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae during nonoutbreak situations in Spain. J Clin Microbiol 2004, 42:4769-4775.
4. Rodríguez-Baño J., Navarro M.D., Romero L., et al. Epidemiology and clinical features of infections caused by extended-spectrum beta-lactamase-producing Escherichia coli in nonhospitalized patients. J Clin Microbiol 2004, 42:1089-1094.
5. Livermore D.M., Canton R., Gniadkowski M., et al. CTX-M: changing the face of ESBLs in Europe. J Antimicrob Chemother 2007, 59:165-174.
6. Cantón R., Coque T.M. The CTX-M [beta]-lactamase pandemic. Curr Opin Microbiol 2006, 9:466-475.
7. Bradford P.A. Extended-spectrum β-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev 2001, 14:933-951.
8. Biendo M., Manoliu C., Laurans G., et al. Molecular typing and characterization of extended-spectrum TEM, SHV and CTX-M beta-lactamases in clinical isolates of Enterobacter cloacae. Res Microbiol 2008, 159:590-594.
9. Cohen Stuart J., Dierikx C., Al Naiemi N., et al. Rapid detection of TEM, SHV and CTX-M extended-spectrum beta-lactamases in Enterobacteriaceae using ligation-mediated amplification with microarray analysis. J Antimicrob Chemother 2010, 65:1377-1381.
10. Naas T., Cuzon G., Truong H., Bernabeu S., Nordmann P. Evaluation of a DNA microarray, the Check-Points ESBL/KPC array, for rapid detection of TEM, SHV, and CTX-M extended-spectrum β-lactamases and KPC carbapenemases. Antimicrob Agents Chemother 2010, 54:3086-3092.
11. Cantón R., Novais A., Valverde A., et al. Prevalence and spread of extended-spectrum beta-lactamase-producing Enterobacteriaceae in Europe. Clin Microbiol Infect 2008, 14(Suppl. 1):144-153.
12. Al Naiemi N., Bart A., de Jong M.D., et al. Widely distributed and predominant CTX-M extended-spectrum β-lactamases in Amsterdam, The Netherlands. J Clin Microbiol 2006, 44:3012-3014.
13. Sturm P.D.J., Bochum E.T.M., van Mook-Vermulst S.V.M., Handgraaf C., Klaassen T., Melchers W.J.G. Prevalence, molecular characterization, and phenotypic confirmation of extended-spectrum beta-lactamases in Escherichia coli, Klebsiella pneumoniae, and Klebsiella oxytoca at the Radboud University Nijmegen medical centre in The Netherlands. Microb Drug Resist 2010, 16:55-60.
14. Thomson K.S., Cornish N.E., Hong S.G., Hemrick K., Herdt C., Moland E.S. Comparison of Phoenix and VITEK 2 extended-spectrum-β-lactamase detection tests for analysis of Escherichia coli and Klebsiella isolates with well-characterized β-lactamases. J Clin Microbiol 2007, 45:2380-2384.
15. Wiegand I., Geiss H.K., Mack D., Stürenburg E., Seifert H. Detection of extended-spectrum beta-lactamases among Enterobacteriaceae by use of semiautomated microbiology systems and manual detection procedures. J Clin Microbiol 2007, 45:1167-1174.
16. Bonnet R. Growing group of extended-spectrum β-lactamases: the CTX-M enzymes. Antimicrob Agents Chemother 2004, 48:1-14.
17. Smet A., Martel A., Persoons D., et al. Characterization of extended-spectrum beta-lactamases produced by Escherichia coli isolated from hospitalized and nonhospitalized patients: emergence of CTX-M-15-producing strains causing urinary tract infections. Microb Drug Resist 2010, 16:129-134.
18. Moubareck C., Daoud Z., Hakimé N.I., et al. Countrywide spread of community- and hospital-acquired extended-spectrum β-lactamase (CTX-M-15)-producing Enterobacteriaceae in Lebanon. J Clin Microbiol 2005, 43:3309-3313.
19. Pitout J.D., Laupland K.B. Extended-spectrum β-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect Dis 2008, 8:159-166.
20. Oostdijk E.A.N., de Smet A.M.G.A., Blok H.E.M., et al. Ecological effects of selective decontamination on resistant gram-negative bacterial colonization. Am J Respir Crit Care Med 2010, 181:452-457.
21. Hoffmann H., Stürenburg E., Heesemann J., Roggenkamp A. Prevalence of extended-spectrum beta-lactamases in isolates of the Enterobacter cloacae complex from German hospitals. Clin Microbiol Infect 2006, 12:322-330.
22. Sanders W.E., Sanders C.C. Enterobacter spp.: pathogens poised to flourish at the turn of the century. Clin Microbiol Rev 1997, 10:220-241.
23. Munday C.J., Whitehead G.M., Todd N.J., Campbell M., Hawkey P.M. Predominance and genetic diversity of community- and hospital-acquired CTX-M extended-spectrum β-lactamases in York, UK. J Antimicrob Chemother 2004, 54:628-633.
24. Choi S., Lee J.E., Park S.J., et al. Prevalence, microbiology, and clinical characteristics of extended-spectrum beta-lactamase-producing Enterobacter spp., Serratia marcescens, Citrobacter freundii, and Morganella morganii in Korea. Eur J Clin Microbiol Infect Dis 2007, 26:557-561.